Vis enkel innførsel

dc.contributor.authorSivertsen, Børge
dc.contributor.authorPallesen, Ståle
dc.contributor.authorGlozier, Nick
dc.contributor.authorBjorvatn, Bjørn
dc.contributor.authorSalo, Paula
dc.contributor.authorTell, Grethe Seppola
dc.contributor.authorUrsin, Reidun
dc.contributor.authorØverland, Simon
dc.date.accessioned2014-09-11T12:21:21Z
dc.date.available2014-09-11T12:21:21Z
dc.date.issued2014-07-15eng
dc.identifier.issn1471-2458
dc.identifier.urihttps://hdl.handle.net/1956/8448
dc.description.abstractBackground: Previous research suggests a possible link between insomnia and mortality, but findings are mixed and well-controlled studies are lacking. The aim of the current study was to examine the effect of insomnia in middle age on all-cause mortality. Methods: Using a cohort design with 13-15 years follow-up, mortality registry data were linked to health information obtained during 1997-99, as part of the community-based Hordaland Health Study (HUSK), in Western Norway. 6,236 participants aged 40–45 provided baseline information on self- reported insomnia using the Karolinska Sleep Questionnaire Scale (defined according to the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V), sociodemographic factors, health behaviors, shift/night-work, obstructive sleep apnea symptoms, sleep duration, sleep medication use, anxiety, depression, as well as a range of somatic diagnoses and symptoms. Height, weight and blood pressure were measured. Information on mortality was obtained from the Norwegian Cause of Death Registry. Results: Insomnia was reported by 5.6% (349/6236) at baseline and a significant predictor of all-cause-mortality (hazard ratio [HR] = 2.74 [95% CI:1.75-4.30]). Adjusting for all confounders did not attenuate the effect (HR = 3.34 [95% CI:1.67-6.69]). Stratifying by gender, the effect was especially strong in men (HR = 4.72 [95% CI:2.48-9.03]); but also significant in women (adjusted HR = 1.96 [95% CI:1.04-3.67]). The mortality risk among participants with both insomnia and short sleep duration (<6.5 hours) was particularly high, whereas insomnia in combination with normal/greater sleep duration was not associated with mortality. Conclusions: Insomnia was associated with a three-fold risk of mortality over 13-15 years follow-up. The risk appeared even higher in males or when insomnia was combined with short sleep duration, although such unadjusted subgroup analyses should be interpreted with caution. Establishing prevention strategies and low-threshold interventions should consequently be a prioritized task for public health policy.en_US
dc.language.isoengeng
dc.publisherBioMed Centraleng
dc.rightsAttribution CC BYeng
dc.rights.urihttp://creativecommons.org/licenses/by/4.0eng
dc.subjectInsomniaeng
dc.subjectRisk factoreng
dc.subjectMortalityeng
dc.subjectSleep durationeng
dc.subjectSleep medicationeng
dc.titleMidlife insomnia and subsequent mortality: the Hordaland health studyeng
dc.typePeer reviewed
dc.typeJournal article
dc.date.updated2014-08-27T11:26:27Z
dc.description.versionpublishedVersion
dc.description.versionPeer Reviewed
dc.rights.holderCopyright 2014 Sivertsen et al.; licensee BioMed Central Ltd.
dc.rights.holderBørge Sivertsen et al.; licensee BioMed Central Ltd.eng
dc.source.articlenumber720
dc.identifier.doihttps://doi.org/10.1186/1471-2458-14-720
dc.identifier.cristin1158279
dc.source.journalBMC Public Health
dc.source.4014


Tilhørende fil(er)

Thumbnail
Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution CC BY
Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution CC BY